Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Aeon Biopharma Inc (AEON)

Aeon Biopharma Inc (AEON)
0.4050 x 34 0.4180 x 5
Pre-market by (Cboe BZX)
0.4050 +0.0050 (+1.25%) 04/22/25 [NYSE Arca]
0.4050 x 34 0.4180 x 5
Pre-market 0.4050 unch (unch) 20:00 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.3900
Day High
0.4100
Open 0.3951
Previous Close 0.4000 0.4000
Volume 330,800 330,800
Avg Vol 461,225 461,225
Stochastic %K 12.63% 12.63%
Weighted Alpha -94.73 -94.73
5-Day Change -0.0050 (-1.22%) -0.0050 (-1.22%)
52-Week Range 0.3750 - 402.4800 0.3750 - 402.4800
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,213
  • Shares Outstanding, K 10,533
  • Annual Sales, $ 0 K
  • Annual Income, $ 42,010 K
  • EBIT $ 73 M
  • EBITDA $ 73 M
  • 60-Month Beta 0.35
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -39.41
  • Most Recent Earnings $3.75 on 03/24/25
  • Next Earnings Date 05/13/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -13.67
  • Number of Estimates 1
  • High Estimate -13.67
  • Low Estimate -13.67
  • Prior Year -20.14
  • Growth Rate Est. (year over year) +32.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3750 +8.00%
on 04/11/25
Period Open: 0.6700
0.7399 -45.26%
on 03/25/25
-0.2650 (-39.55%)
since 03/21/25
3-Month
0.3750 +8.00%
on 04/11/25
Period Open: 8.9712
11.0232 -96.33%
on 01/24/25
-8.5662 (-95.49%)
since 01/22/25
52-Week
0.3750 +8.00%
on 04/11/25
Period Open: 339.8400
402.4800 -99.90%
on 04/29/24
-339.4350 (-99.88%)
since 04/22/24

Most Recent Stories

More News
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

AEON : 0.4050 (+1.25%)
AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer

AEON : 0.4050 (+1.25%)
Mineralys, Sana, Aeon: These 3 Biotech Stocks Saw The Sharpest Retail Interest Spike In Q1

Three small-cap stocks have intrigued Stocktwits users the most among the biotech sector this year, thanks to promising data from clinical trials and a leadership shuffle.

SANA : 1.7300 (+8.81%)
MLYS : 13.21 (-0.23%)
AEON : 0.4050 (+1.25%)
AEON Biopharma Announces CEO Transition

AEON : 0.4050 (+1.25%)
AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

AEON : 0.4050 (+1.25%)
AEON Biopharma, Inc. to Participate in the Leerink Global Healthcare Conference

AEON : 0.4050 (+1.25%)
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week

New trial data, a reverse split, and financing moves triggered a spike in retail chatter for these biotech stocks in the week ending Feb. 28, 2025.

TLSA : 1.1600 (+2.65%)
AIM : 0.0949 (-19.37%)
PEPG : 1.6200 (+6.58%)
AEON : 0.4050 (+1.25%)
MBRX : 1.0500 (+10.50%)
AEON Biopharma, Inc. Announces Reverse Stock Split

AEON : 0.4050 (+1.25%)
AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

AEON : 0.4050 (+1.25%)
Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why

Biotech remains a high-risk, high-reward sector, and this month’s top draws reflect retail’s appetite for stocks with major clinical and regulatory catalysts.

KAPA : 0.8948 (-1.90%)
SANA : 1.7300 (+8.81%)
SLXN : 0.7030 (-2.59%)
AEON : 0.4050 (+1.25%)
CRGX : 4.60 (unch)

Business Summary

AEON Biopharma Inc. is a clinical-stage biopharmaceutical company. It focused on developing a proprietary botulinum toxin complex for the treatment of multiple debilitating medical conditions. AEON Biopharma Inc., formerly known as Priveterra Acquisition Corp., is based in IRVINE, Calif.

See More

Key Turning Points

3rd Resistance Point 0.4333
2nd Resistance Point 0.4217
1st Resistance Point 0.4133
Last Price 0.4050
1st Support Level 0.3933
2nd Support Level 0.3817
3rd Support Level 0.3733

See More

52-Week High 402.4800
Fibonacci 61.8% 248.8759
Fibonacci 50% 201.4275
Fibonacci 38.2% 153.9791
Last Price 0.4050
52-Week Low 0.3750

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro